NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
82 hedge funds and large institutions have $49.9M invested in Niagen Bioscience, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 30 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
-1
Holders Change %
-1.2%
% of All Funds
1.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
18
Reduced
30
Closed
13
Calls
$478K
Puts
$255K
Net Calls
+$223K
Net Calls Change
+$192K
Top Buyers
| 1 |
TCM
Tieton Capital Management
Yakima,
Washington
|
+$2.49M |
| 2 |
Renaissance Technologies
New York
|
+$940K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$591K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$446K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$193K |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$1.55M |
| 2 |
Barclays
London,
United Kingdom
|
-$1.4M |
| 3 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
-$1M |
| 4 |
Millennium Management
New York
|
-$845K |
| 5 |
Goldman Sachs
New York
|
-$186K |
